Catalyst Wire Dossier Catalyst Wire Dossier

Gonyautoxins NEURO SERUM

· Algenis SpA
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Gonyautoxins NEURO SERUM, covering 2024-02-01 to 2024-02-01. Get the full timeline:

Most recent: Clinical Trial Update: Proof of Principle Study Evaluating Gonyautoxins NEURO SERUM, on Chemotherapy-induced Peripheral Neuropathy [Phase 1, Phase 2]

See pricing